Changes in osteoblastic activity in patient who received bortezomib as second line treatment for plasma cell myeloma: A prospective multicenter study

Ki Seong Eom, Seok Jin Kim, Je Jung Lee, Cheolwon Suh, Jin Seok Kim, Sung Soo Yoon, Byung Soo Kim, Hye Jin Kang, Young Jin Choi, Chul Soo Kim, Yang Soo Kim, Jae Yong Kwak, Yoo Jin Kim, Young Don Joo, Yeung Chul Mun, Deog Yeon Jo, Joon Seong Park, Chi Young Park, Sung Hyun Kim, Chang Ki Min

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Changes in osteoblastic activity in patient who received bortezomib as second line treatment for plasma cell myeloma: A prospective multicenter study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds